A source close to the client confirmed that Omnicom's OMD and IPG's Universal McCann, both incumbents in their respective regions, will hold to their status in Asia. It is unclear, however, how J&J will split its media duties elsewhere.
The result deals a blow to J&J's other incumbent, IPG's Initiative, and Carat, which was invited to join the pitch last month (Media May 7). J&J spends approximately US$300 million on media in Asia Pacific, the bulk of which is in China and Southeast Asia.
The consumer healthcare giant kicked off the review in April, soon after the company's acquisition of Pfizer Consumer Healthcare in 2006. The process has been managed by R3.
J&J tipped to select OMD and Universal McCann
SINGAPORE - Johnson & Johnson (J&J) has all but concluded its global US$3 billion media review, appointing its China account to OMD and the Southeast Asia portion to Universal McCann.
